Clinical Trial Update: Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation [Phase 2]

View source ↗

Summary

Phase 2 clinical study evaluating the antihyperlipidemic effects of a classical Unani antiobesity formulation in hyperlipidemia; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Classical Unani antiobesity formulation

Snippet

Sponsor: Jamia Hamdard University | Conditions: Hyperlipidemia | Phase 2 | Status: COMPLETED